-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Elevance Health, Raises Price Target to $406

Benzinga·10/22/2026 11:25:01
Listen to the news
Baird analyst Michael Ha maintains Elevance Health (NYSE:ELV) with a Neutral and raises the price target from $393 to $406.